|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.3 SEK | +0.70% |
|
+1.41% | +29.64% |
| Apr. 22 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
| Feb. 13 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
EQL Pharma AB (publ) announced that the company's long-term financial goals remain unchanged, as does the sales forecast for the full year 2023/24, where they forecast growth of around 30%.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.64% | 115M | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
EQL PHARMA AB 
